Merck KGaA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| MKGAF | KNSA | ZTS | RDY | TKNO | KMDA | |
|---|---|---|---|---|---|---|
| Market cap | 70.35B | 6.13B | 32.80B | 10.89B | 380.11M | 447.83M |
| P/E (TTM) | 25.4 | 79.4 | 13.1 | 29.7 | — | 20.4 |
| Forward P/E | — | 48.6 | 12.1 | 19.9 | -37.3 | 13.5 |
| Price/book | 2.1 | 9.4 | 10.4 | 16.1 | 6.1 | 1.7 |
| Dividend yield | 1.65% | — | 2.67% | 0.64% | — | 2.17% |
| 1-year change | +19.06% | +106.88% | −45.28% | −11.39% | +23.13% | +16.00% |
| Today | +3.55% | −1.69% | +1.22% | +1.32% | −6.84% | −0.89% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All MKGAF news ›Adlai Nortye lines up Lilly, Merck KGaA for AN4035 trial
Adlai Nortye Group Ltd (NASDAQ: ANL) said on 15 October 2026 it has entered a clinical trial collaboration and supply agreement with Eli Lilly and Company (NYSE: LLY) and Merck KGaA, Darmstadt, Germany, to test its experimental cancer drug…
Merck KGaA: Relative Strength Chart - Stock Xetra
Compare Merck KGaA with the company of your choice via a Relative Strength chart. Real-time MRK price, Xetra stock exchange Relative Strength Chart Merck KGaA All financial news and data tailored to specific country editions
Merck KGaA: Total Return chart (Dividends reinvested) - Xetra stock market
See the history of Merck KGaA, with dividends reinvested. (Total Return chart) MRK Stock market Total Return chart Merck KGaA Past dividends on Merck KGaA All financial news and data tailored to specific country editions
Merck KGaA's Diabetic Macular Edema Drug Meets Primary Endpoint in Clinical Trial
Published on 10/11/2026 at 07:14 am EDT Merck: Operational resilience over the years, cannot be overlooked September 04, 2026 at 08:34 am EDT Merck KGaA: From 19th-century cocaine to tomorrow's AI chips Merck CEO on US Business, Life…
Adlai Nortye Enters Clinical Trial Deals With Eli Lilly, Merck KGaA
Adlai Nortye signed clinical trial collaboration and supply agreements with Eli Lilly and Merck KGaA to evaluate its investigational cancer drug AN4035 in combination with cetuximab, the company... Adlai Nortye Group Ltd. Biotechnology &…
Adlai Nortye Group Ltd. Enters Into Clinical Collaboration With Eli Lilly And Company And Merck KGaA, Darmstadt, Germany To Evaluate Combination Of AN4035 And Cetuximab
Adlai Nortye Group Ltd. on October 15, 2026 announced clinical trial collaboration and supply agreements with Eli Lilly and Company and Merck KGaA, Darmstadt, Germany for the anti-EGFR antibody... Adlai Nortye Group Ltd on October 15, 2026…
Biopharmaceutical Single Use Mixing Bags Market is Booming Worldwide|• Thermo Fisher Scientific • Sartorius AG • Merck KGaA
The global Biopharmaceutical Single Use Mixing Bags Market is witnessing evolving industry dynamics driven by technological advancements changing customer requirements and emerging business opportunities In its latest research publication…
Price to cash flow ratio of Merck KGaA Sponsored ADR – HAN:MRKC
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other.…
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TradingView Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 12.10.2026 / 10:25 CET/CEST Legal entity: AVGP LimitedCity of registered…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
openpr.com7
-
marketscreener.com4
-
themarketsdaily.com2
-
tradingview.com2
-
bioprocessintl.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.